Co-administered antibody improves penetration of antibody–dye conjugate into human cancers with implications for antibody–drug conjugates
Antibody-drug conjugates targeting high expression receptors can suffer from poor tumour penetration. Here, the authors use unconjugated antibody to improve the penetration of an antibody-dye conjugate in a clinical study, supporting further clinical investigation of the co-administration strategy.
Guardado en:
Autores principales: | Guolan Lu, Naoki Nishio, Nynke S. van den Berg, Brock A. Martin, Shayan Fakurnejad, Stan van Keulen, Alexander D. Colevas, Greg M. Thurber, Eben L. Rosenthal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1938690d6e61435ab3bfc4f49f1afa68 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
por: Naoki Nishio, et al.
Publicado: (2019) -
Antibody Drug Conjugates in Glioblastoma – Is There a Future for Them?
por: Sagun Parakh, et al.
Publicado: (2021) -
Potent Killing of Pseudomonas aeruginosa by an Antibody-Antibiotic Conjugate
por: Kimberly K. Kajihara, et al.
Publicado: (2021) -
Incorporation of Unnatural Amino Acid into Antibody Fragment for Creating a Stable Antibody Drug Conjugate
por: Andri Wardiana, et al.
Publicado: (2021) -
Non-specific interactions of antibody-oligonucleotide conjugates with living cells
por: Victor Lehot, et al.
Publicado: (2021)